Tumour-Infiltrating Clonal Haematopoiesis Increases the Risk of Recurrence or Death Among Patients with NSCLC and the Risk of Death From Any Cause Among Patients with Solid Tumours By Ogkologos - May 7, 2025 618 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the analysis of TRACERx and MSK-IMPACT studies Source RELATED ARTICLESMORE FROM AUTHOR Antitumour Activity of Rezatapopt Provides Proof of Concept for p53 Reactivation in Patients with TP53 Y220C-mutated Solid Tumours Rare Disease Day 2026: Advancing equity for people living with rare cancers in Europe EMA Recommends Extension of Therapeutic Indications for Ponatinib MOST POPULAR Reunión anual de la American Society of Clinical Oncology (ASCO) de... June 3, 2022 Loss of Y Chromosome in Men Makes Bladder Cancer More Aggressive July 27, 2023 New Treatment Approach Could Help Prevent Recurrences of Some Bladder Cancers May 31, 2018 Two Years After Cancer Diagnosis, Swimmer Rikako Ikee Has Qualified For... April 7, 2021 Load more HOT NEWS Shannon’s Law Requires NY Insurance Companies to Cover Mammograms for Ages... ESMO World Congress on Gastrointestinal Cancer 2021, 30 June – 3... Distinct and Overlapping Pathways Contribute to the Efficacy of Nivolumab-Based Regimens... Uncle Charlie’s Promise
